InvestorsHub Logo
Followers 21
Posts 3570
Boards Moderated 0
Alias Born 12/18/2019

Re: LearningEveryTrade post# 542976

Saturday, 12/03/2022 3:16:05 PM

Saturday, December 03, 2022 3:16:05 PM

Post# of 701980
NWBO is going to be deep into 2024 before they are going to be competitive in the U.S. NVCR is more focused on the rest of the indications that are expected in 2023 -- NSCLC, pancreatic, ovarian and brain metastasis indications are coming. Much larger revenue potential that GBM.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News